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Abstract
Objective: A number of small portable systems that can measure HRV are available
to address questions related to autonomic regulation in free-living subjects. However,
ambulatory HRV measurements obtained through use of these systems have not
previously been validated against standard clinical measurements such as Holter
recordings. The objective of this study was to validate HRV obtained using a
commonly used system, Actiheart, during occupational and leisure-time activities.
Method: Full-day ambulatory electrocardiography (ECG) signals were recorded from
8 females simultaneously using Actiheart and Holter recorders, and signals were
processed to RR-interval time series. Segments of 5-minute duration were sampled
every 30 minutes, and spectral components of the heart rate variability were
calculated. Actiheart and Holter values were compared using Deming regression
analysis and Bland-Altman plots.
Results: In total, 489 segments were available with an HRV value from both Actiheart
and Holter recordings after filtering out segments with >10% interpolated beats. No
systematic differences between Actiheart and Holter HRV were found. The random
deviations between Actiheart and Holter were comparable to the repeatability
standard deviation between consecutive Holter measurements.
Discussion: The results show that Actiheart is suited as a stand-alone ambulatory
method for heart rate variability monitoring during occupational and leisure-time
activities.
Keywords: Autonomic nervous system field study, Holter monitoring, method
comparison
Background
Cardiovascular disease (CVD) is by far the leading cause of morbidity and mortality in
Western societies [1]. Factors in the working environment are considered to enhance
the risk of CVD [2-4]. This association is generally explained by elevated stress
responses, including increased sympathetic dominance of the cardiac autonomic
nervous system from a poor work environment [5,6], which in the long run enhances
the risk of CVD [3].
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reproduction in any medium, provided the original work is properly cited.Heart rate variability (HRV) is a well-recognized method for assessing activity of the
cardiac autonomic nervous system [7,8]. HRV has been shown to be a strong predictor
for mortality after acute myocardial infarction [9,10] and CVD in healthy subjects
[11-13]. Therefore, HRV is regarded to be a useful non-invasive predictor for CVD.
HRV is increasingly being used for measuring the activity of the cardiac autonomic
nervous system in relation to work [14]. Although HRV is influenced by physical activ-
ity [15,16], studies using ambulatory HRV monitoring during work have not controlled
for physical activity [14,17]. High levels of physical activity at work are shown to
enhance the risk of CVD [18,19] and CVD mortality in persons of low fitness [20,21].
Therefore, valid ambulatory monitoring of HRV during activities of free living (i.e.
work, leisure time and sleep) is required.
Monitoring HRV in subjects during free living is challenging compared to monitoring
HRV under controlled conditions. The equipment should not interfere with the activities
undertaken by the subjects, including strenuous work, awkward work postures, sports
activities, etc. Sleep may present another type of challenge because leads and electrodes
may feel annoying and could interfere with movements during sleep. Recently, small and
robust monitors have been developed for monitoring during training and exercise that
enable long-term electrocardiac monitoring as well as accelerometry [22-25]. These
monitors allow researchers to address questions related to physical activity at work and
during leisure time that have hitherto been difficult to approach.
While the performance of different algorithms used to process this time series has
been investigated and compared in a number of contexts, for example, [26-28], the
reliability of the sampling of raw data, that is, the interbeat interval time series, using
the small portable monitors in free-living subjects has to our knowledge not been
investigated. Usually, only the timing of the heart beats is recorded in these systems.
Thus, checking the electrocardiogram for noise and other artefacts is not an option.
This is potentially a serious concern when collecting heart beat recordings from physi-
cally active free-living subjects.
Actiheart (CamNtech Ltd U.K.) is a small lightweight system that has been applied in
a few studies for monitoring HRV [29,30]. Actiheart has been subjected to a number of
validation studies; however, these studies have primarily focused on validating move-
ment and heart rate (HR) detection. Thus, Brage et al. [23] did not find any significant
difference in HR detected by Actiheart and in standard ECG recordings in 9 subjects
engaged in various activities according to an exercise protocol. Also Barreira et al. [22],
in a larger study encompassing 34 subjects, did not find any differences in HR esti-
mated by Actiheart and in standard ECG recordings during standardized exercise.
However, in free-living unspecified physical activity of 30 minutes duration, these
authors observed that Actiheart overestimated HR by 3% compared to the reference
system (Polar Vantage XL HRM, Polar Electro OY, Finland). These findings underscore
the need to conduct at least part of the testing and validation under realistic condi-
tions. Energy expenditure measurements by Actiheart have been validated under field
conditions [24]. However, Actiheart HRV measurements have not previously been vali-
dated under field conditions. The objective of the present study was therefore to com-
pare Actiheart ambulatory heart rate variability monitoring during activities of work,
leisure time and sleep with HRV obtained using a state-of-the art clinical measurement
(Holter monitoring). Specific aims were to compare 1) frequency domain HRV metrics
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dom deviations between HRV metrics obtained using these two techniques. For this
purpose, ambulatory ECG was simultaneously measured with Actiheart and Holter
monitors during work, leisure time and sleep in workers with physically demanding
work (female cleaners).
Methods
Study population
Eight Caucasian women were recruited from a group of cleaning assistants who work
more than 20 hours/week at a university hospital in Copenhagen, Denmark. Two of
the subjects were diagnosed with hypertensio na n du s e dp r e s c r i b e da n t i h y p e r t e n s i v e
medicine. Physical and physiological characteristics of the participants are summarized
in Table 1. All participants were informed about their voluntary participation [31], and
provided with a written informed consent. Ethical approval was received from the local
ethics committee (H-D-2009-041).
Study procedure
The study was performed at the participants’ workplace during working hours. In the
morning (during the first three hours of their workday), the participants met with the
test instructor at their workplace, and the monitors (Actiheart and Holter) were firmly
fixed to their chests. The same instructor placed electrodes and monitors on all partici-
pants. The recording lasted approximately 24 hours, covering work, leisure time and
sleep. Six of the participants were measured twice and two participants once, yielding
a total of 14 ambulatory ECG recordings available for analysis. The participants were
informed to do their daily activities as usual and they received a diary in which they
were asked to register their daily activities during the recording, and they also received
an information sheet about the monitors and the recording.
Instrumentation and tachograms
Standard ECG Holter monitoring was made using LifeCard CF recorders (Del Mar
Reynolds Medical Inc., USA), employing a 3-lead, 3-channel recording setup with a
sampling frequency of 128 Hz. The three electrodes for the Holter Monitor measure-
ment were placed on the right and left side of the chest, at the level of the 6
th costa
and on the manubrium of sternum (Figure 1). Deviating beat forms, premature beats,
Table 1 Characteristics of the participants (n = 8)
Mean SD Range
Age (years) 35.50 17.36 19 - 58
Height (cm) 169.88 6.01 158 - 177
Weight (kg) 75.03 15.46 51.2 - 100.2
BMI (kg/m
2) 25.90 4.70 20.2 - 33.5
Fat% 34.36 9.53 17 - 45
Waist circumference (cm) 88.08 13.93 72 - 106
Waist - hip ratio 0.79 0.14 0.53 - 0.98
Aerobic fitness (mL O2/min/kg) 27.93 4.75 19.9 - 33.7
Sleeping heart rate (beats/min.) 54.04 5.94 47 - 66
Systolic blood pressure (mmHg) 117.38 10.64 98 - 132
Diastolic blood pressure (mmHg) 78.21 8.94 64 - 87
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(Impresario ver. 2.8, Del Mar Reynolds Medical Inc.) and verified by visual inspection.
The Impresario algorithm for detection of ectopic beats has been validated against the
MIT arrhythmia database, and has a sensitivity and positive predictive power of,
respectively, 99.3% and 99.7% according to information provided by the manufacturer.
In order to avoid jitter in the estimation of the R-wave fiducial point, a sampling rate
of at least 250 Hz is normally recommended [7]. However, satisfactory R-wave fiducial
point estimation can be obtained by interpolation, such as cubic spline interpolation
[7,32]. Therefore, the RR intervals were subsequently recalculated using a resampled
ECG signal derived from the original ECG signal by cubic-spline interpolation from
128 Hz to 512 Hz. Although the ECG has been screened for beats deviating from
s i n u sr h y t h mb e a t s( s e ea b o v e )e x p e r i e n c e has shown us that further processing is
necessary to prepare the RR interval series for frequency domain analyses of HRV. We
therefore applied the algorithm proposed by Clifford et al. [33]. In brief, RR interval
outliers were defined as RR-intervals in which both |ΔRRn|a n d| ΔRRn+1|a r eg r e a t e r
than δ,w h e r eΔRRn i st h er e l a t i v ec h a n g ei nn
th RR-interval. A value of δ =0 . 1 5w a s
used. Finally, the RR-intervals (the tachogram) were resampled with a frequency of 4
Hz and linearly detrended.
The Actiheart recorder was fixed to the participants’ upper chest by clips that fit
standard ECG electrodes. The Actiheart recorder was firmly fixed to an electrode
placed just below the apex of sternum while the wire running from the monitor was
fixed to an electrode placed on the same horizontal level and as lateral as possible
(Figure 1). This placement is associated with higher ECG amplitudes and a lower level
of noise from movement artefacts, and orientated to measure acceleration along the
longitudinal axis of the body [23]. Before application, the electrode placement area was
prepared by cleaning the skin with 73% ethanol spirits. The procedure and electrodes
Figure 1 Position of electrodes for the Holter monitor and Actiheart, respectively.
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Page 4 of 14used (gelled foam Delmar-Reynolds Holter/Stress) was the same for both the Actiheart
and the Holter monitor recordings. In the Actiheart recorder, the analog signal was
band-pass filtered (10-35 Hz), sampled with a frequency of 128 Hz, and processed by a
real time QRS-detection algorithm (Actiheart User Manual, 1999). During the record-
ing, interpolated RR intervals with a resolution of 1 ms were stored in the memory. In
the recording mode employed in the present study, the raw ECG signal is not stored
by the Actiheart recorder. Since the RR-intervals stored in the Actiheart recorder were
not filtered beforehand, a thorough filtering was necessary before calculation of HRV
for excluding abnormal RR-intervals from the tachogram. A fourstep procedure was
applied, A-B-B-A, where A constitutes a similar filtering process as for the Holter
recordings, and B the following method: if |ΔRRn|>2δ then dn-1= |RRn-1-M| and dn=
|RRn-M| are calculated, where M is the median of the RR-intervals in the actual
5-min. segment. If dn-1 >d n then RRn-1 is excluded and if dn-1 <d n then RRn is
excluded from the RR-intervals.
Estimation of spectral components of HRV
The same mathematical algorithm was used to calculate HRV from Holter and Acti-
heart tachograms. In brief, the spectral components of the HRV for 5-min segments of
the tachogram were estimated using Welch’s averaged, modified periodogram method
(Hamming window size 256 points, 50% overlap) [34]. Mean heart period (mean RR
interval length) and total power (TP) were calculated for the frequency range 0.0003-
0.5 Hz, low frequency power (LFP) in the range 0.04-0.15 Hz and high frequency
power (HFP) in the range 0.15-0.4 Hz. Power was expressed in absolute units (ms
2)
and in normalized units (n.u.) by dividing LFP, respectively HFP, with the power in the
frequency range 0.04-0.5 Hz. These power ranges correspond to the Task Force
recommendations [7], except for the fact that the very high frequency range (0.4-
0.5 Hz) is included in the total power frequency range by default in the Impresario
software. However, since the power in the very high frequency range is very small
compared to LFP and HFP power, this makes no significant difference with regard to
the calculations of TP, LFn.u. and HFn.u. Finally, the ratio of power in the low fre-
quency range to the power in the high frequency range, LF/HF, was also calculated.
Only ECG recordings with ≤ 10% interpolated beats were used.
Comparison of Actiheart and Holter recordings
We selected 5-min ECG segments starting every 30 min throughout the whole record-
ing starting at the first available half hour, yielding 40 segments for the majority of the
recordings. This sampling procedure was preferred in order to obtain approximate sta-
tistical independency of the measurements obtained in each subject. Systematic devia-
tions between HRV metrics estimated on the basis of Actiheart and Holter recordings
were investigated using Deming regression models. Contrary to ordinary least square
regression, Deming regression allows errors in both variables. Deming regression is
therefore preferable over least square regression in method comparison studies [35].
The random nature of the differences between Actiheart and Holter values was investi-
gated by comparison with the repeatability standard deviation. The repeatability stan-
dard deviation expresses the variation of measurements from consecutive 5-min
segments under stationary conditions. The repeatability standard deviation therefore
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this study, the repeatability standard deviation was estimated based on data from a pre-
vious study on biological and seasonal components of variation in HRV [36]. In brief,
HRV was measured monthly in 19 persons for one year, and weekly for one month. At
each time of measurement, HRV was measured in seated position for 15 min, resulting
in three ECG segments of 5min duration. Applying a variance component model to
the dataset allowed for estimation of the standard deviation between the HRV values
measured for these three ECG segments, that is, the repeatability standard deviation.
Results
Of a total of 582 recorded ECG segments, acceptable HRV values from both Actiheart
and Holter systems were obtained in 489 segments based on the ≤10% interpolated
beats criterion. More ECG segments were rejected in Actiheart (n = 69) compared to
Holter (n = 28). Four ECG segments were rejected in both the Actiheart and Holter
methods. Of the 513 ECG segments accepted by the Actiheart system, 24 (4.7%) were
rejected in Holter analysis. An examination of the Holter ECG recordings revealed that
extrasystoles and other arrhythmias were generally absent except for some normal
respiratory sinus arrhythmia during sleep, and that the reason for rejection in Holter
analysis was a large amount of interference from movement artefacts or electric activity
from skeletal muscles or a combination of both. In the following analyses only the 489
segments with accepted HRV values from both the Actiheart and Holter systems are
used.
The relations between the HRV variables obtained using Actiheart and Holter are
illustrated in Figures 2 and 3, and the estimated slopes and intercepts of the Deming
regression analysis are presented in Table 2. The slopes are in all cases close to 1 and
the deviations are in all cases ≤ 3%, and intercepts close to 0. The slopes of Actiheart
versus Holter HRV are significantly smaller than 1 for HFn.u., ln(TP), ln(HFP) and ln
(LF/HF). Excluding data from the two subjects using antihypertensives did not change
the slopes and intercepts presented in Table 2.
In order to investigate the magnitude of the random variation of the differences
between the measurement results, standardized differences (z) were calculated as z =
(Actiheart - Holter)/srepeatability, where srepeatability is the repeatability standard deviation.
Figure 4 presents Bland-Altman-like plots [37] of the standardized differences versus
the mean of the Actiheart and Holter HRV measurements. For all HRV measurements
the deviations from the standardized difference (z = 0) appear to be equally distributed
around 0. There is no clear tendency for the largest standardized differences to depend
on the mean value. An inspection of the extreme values showed that they originated
from different participants. For some of the variables, most notably for LFn.u. and
HFn.u., the distribution of |z|-values > 1 is skewed with more extreme z-values at high
HRV (for example, LFn.u.) or low HRV (for example, HFn.u.). However, from Figure 4
it is obvious that the skewed distribution of high or low z-values reflects the underlying
density of HRV measurements and that the distribution is therefore not caused by a
truly skewed distribution of the random errors. For example, there are very few |z|-
values > 1 for LFn.u. > 0.5 because there are very few measurements in this range
(Figure 4f). The number of standardized differences exceeding ±1 and ±2, respectively,
are shown in Table 3. From 4 to10% exceed ±1while 0.8-2.5% of the values exceed ±2.
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and 5% exceeding ±1 and ±2, respectively.
Lastly, Figure 5 presents data for the mean heart period and selected HRV measure-
ments representing the total HRV (ln(TP)), the parasympathetic modulation of the
autonomic cardiac regulation (ln(HFP)) and the autonomic balance (ln(LF/HF)) in the
eight cleaning workers during a whole workday. Statistical analyses showed differences
in heart period (lower heart rate) in the order sleep>leisure time>work (and break dur-
ing work) (one-way ANOVA, P < 0.001). With regard to the HRV measurements,
sleep was associated with parasympathetic dominance (higher total HRV and high fre-
quency power, and lower ln(LF/HF)) (all P < 0.01), while no significant differences
were observed during work and leisure periods.
Discussion
Actiheart is a validated system for estimating energy expenditure based on electrocar-
diography (ECG) and accelerometry sensors [22-24]. The system is similar to other
small portable systems used for shorter activities, e.g. exercise and training, in that the
ECG cannot be stored, except for short recordings. It is therefore possible that noise,
unchecked artefacts and non-normal beats, the latter well-known to significantly affect
short-term HRV [38], might lower the quality of the HRV measurements obtained by
the Actiheart recorder. In addition, Actiheart is a 2-lead system making it more vulner-
able to electrode problems than systems with more leads. This problem could be more
Figure 2 Ambulatory HRV measurements of Actiheart versus Holter system; a) ln(TP); b) ln(LFP); c)
ln(HFP); d) ln(LF/HF).
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Page 7 of 14Figure 3 Ambulatory HRV measurements of Actiheart versus Holter system; a) RRmean; b) LFn.u.;
c) HFn.u.
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Page 8 of 14Table 2 Slopes and intercepts (95% CI) estimated by Deming regression analyses of
Actiheart versus Holter (n = 489) HRV measures.
Slope 95%CI Intercept 95%CI
RRmean 0.998 (0.994 - 1.001) 1.91 (-0.515 - 4.332)
LFn.u. 0.981 (0.962 - 1.001) 0.01 (-0.014 - 0.027)
HFn.u. 0.980* (0.964 - 0.997) 0.01 (-0.002 - 0.022)
ln(TP) 0.977* (0.962 - 0.994) 0.17* (0.047 - 0.289)
ln(LFP) 0.995 (0.977 - 1.013) 0.03 (-0.088 - 0.166)
ln(HFP) 0.971* (0.950 - 0.991) 0.19* (0.061 - 0.315)
ln(LF/HF) 0.973* (0.950 - 0.995) 0.00 (-0.043 - 0.034)
Significantly different from 1 (slopes) or 0 (intercepts); *P < 0.05.
Figure 4 Standardized differences of (Actiheart - Holter) HRV measures versus the mean value; a)
ln(TP); b) ln(LFP); c) ln(HFP); d) ln(LF/HF); e) LFn.u.; f) HFn.u.
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during leisure time.
In this study, we compared HRV measurements obtained through ambulatory Acti-
heart and Holter monitoring during an entire day. Since it is well known that different
spectral analysis methods can produce different results [28,34], the tachograms from
both Actiheart and Holter underwent the same spectral analysis. Likewise, the electro-
des were attached by the same person to avoid influence from intertechnician effects.
Differences in HRV must therefore be attributed to differences in the recorded ECG
signal, different processing procedures by hardware and embedded software, as well as
slightly different filtering procedures applied to the raw tachograms prior to spectral
analysis.
Overall, no marked systematic differences between HRV measurements obtained by
Actiheart and Holter were observed. The regression of Actiheart versus Holter values
of HFn.u., ln(TP), ln(HFP) and ln(LF/HF) yielded slopes significantly different from 1.
However, the differences were within a 3%-range, and therefore considered to have no
practical relevance since the relative within-subject standard deviations of ln(TP), HFn.u.,
Table 3 Number of ECG time segments for which the standardized difference between
Actiheart and Holter HRV estimates (in units of repeatability standard deviations, z)
exceeds 1 and 2, respectively
HRV
metric
s (repeatability) Number of
segments z>1
Percentage of
total
a
Number of
segments z>2
Percentage of
total
a
ln(TP) 0.41 19 3.9% 4 0.8%
ln(LFP) 0.39 28 5.7% 10 2.0%
ln(HFP) 0.50 37 7.6% 12 2.5%
ln(LF/HF) 0.41 47 9.6% 12 2.5%
LFn.u. 0.078 39 8.0% 12 2.5%
HFn.u. 0.078 32 6.5% 8 1.6%
aTotal n = 489 ECG segments.
Figure 5 Mean heart period (RRmean) and heart rate variability indices of 8 cleaning workers
during a workday.a )R R mean, b) ln(LF/HF), c) ln(TP) and d) ln(HFP) derived from 5 min recordings sampled
every 30 min. Measurements are categorized according to work period (9:00 - 13:00), break during work
(11:00), leisure period (13:30 - 22:00) and sleep periods (22:30 - 04:30). Error bars indicate standard error of
the mean.
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Page 10 of 14ln(HFP) and ln(LF/HF) are 6%, 28%, 14% and 77%, respectively [36]. Therefore, although
the Deming regression analyses indicate small yet significant systematic differences
between the Actiheart and Holter for some HRV measurements, the differences are too
small compared to the individual differences to warrant that a correction factor be applied.
The investigation of the distribution of differences between Actiheart and Holter
indicated that the differences seemed to be randomly distributed with a spread not
exceeding that expected from the normal repeatability of measurements using the
same method. The most extreme deviations between the measurements came from dif-
ferent participants, and this supports the interpretation that the differences are caused
by random variations.
Some differences in the processing of the recorded ECG were unavoidable because
different instruments were used. Additional processing of the RR interval series
obtained from Actiheart was deemed necessary in order to obtain RR interval series of
high quality. The procedures for processing ECG and RR interval time series in Holter
and Actiheart are part of our standard protocol when using these instruments. There-
fore, although it is possible that differences in processing of the ECG and RR interval
time series can explain some of the variation between Actiheart and Holter HRV mea-
surements, a comparison of Actiheart and Holter without applying these procotols
would be less relevant. Furthermore, in view of the accordance between Actiheart and
Holter, one can conclude that the contribution to the variation from differences in fil-
tering procedures is likely to be of little importance.
These conclusions pertain to the HRV values accepted by both Actiheart and Holter
measurements. A small number of measurements (n = 24, 4.7%) were accepted by
Actiheart, but not by Holter. Although this proportion is small, it nevertheless suggests
that as many as 5% of the Actiheart values could be erroneous. However, the signal in
the rejected Holter segments was heavily disturbed by interference from electric signals
from other muscles or movement artefacts, which indicates that the underlying “true”
heart beat pattern was a normal sinus rhythm with no more aberrant beats than nor-
mal. However, as raw ECG data from the Actiheart are not available because they are
immediately processed to yield RR-intervals without being stored in the memory, we
are not able to check if Actiheart perhaps ‘missed’ these massive electric disturbances.
Having said that, because the Actiheart electrodes are placed farther from the arms,
the Actiheart electrodes may be better protected under conditions with intense move-
ments in the upper body, and it is therefore possible that Actiheart signals are of good
quality in situations where the Holter signal is unstable. Although we cannot provide
definitive evidence to support this interpretation, there is no evidence to suggest that
HRV values are in error with regard to these segments.
Lastly, a relatively large proportion (11.9%) of Actiheart segments were rejected,
while in Holter analysis, only 5.5% were rejected. That some measurements are
rejected in ambulatory monitoring due to movement artefacts and other interferences
as described above is not surprising. The reason that more segments are rejected in
Actiheart than in Holter might be problems caused by sweat. During the recordings, it
was seen that the electrodes were not resistant to a great amount of sweat, which in
particular was a problem with the electrodes for the Actiheart recordings because of
their position the lower part of the chest. In a situation where one electrode does not
have sufficient skin contact, the Actiheart using only two electrodes will have
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have this problem. Changing the positions of the electrodes may therefore reduce the
loss of data observed in the present study.
The data obtained from the eight cleaners during a workday and night demonstrates
the feasibility of use of the Actiheart system to study work and leisure time cardiac
autonomic activity. The HRV results in Figure 5 indicating an autonomic balance of
more extensive parasympathetic modulation during sleep compared to the wake state
(work, leisure time) are in accordance with previous findings [36,39]. Interestingly, in a
recent study Hautala et al. [40] studied the association between HRV and physical
activity levels, expressed as mean metabolic equivalents (MET) for 30-min blocks, in
free-living conditions. They found that physical activity was significantly associated
with HR and negatively associated with short-term index of HRV and sample entropy,
a measure of the complexity of the HRV. Details of the nature of the physical activity
levels were not given.
In conclusion, good agreement was observed between spectral components of HRV
from ambulatory short-term ECG recordings by the Actiheart and Holter systems.
Although more HRV measurements were rejected in Actiheart compared to Holter
monitoring, this difference was probably caused by technical problems and does not
indicate a problem with Actiheart as such. Thus, Actiheart seems suitable for measure-
ment of HRV during occupational and leisure-time activities. Additional studies includ-
ing more subjects of both genders in different occupations and leisure-time activities
are warranted in order to further explore the utility of Actiheart for measuring HRV in
free-living subjects.
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